Acceptable panel to detect the two most common inherited thrombophilias (prothrombin related and factor V Leiden related).
Polymerase Chain Reaction/Fluorescence Monitoring
New York DOH Approval Status
Lavender (EDTA), pink (K2 EDTA) or yellow (ACD Solution A or B).
Transport 3 mL whole blood. (Min: 2 mL)
Plasma or serum; collection of specimen in sodium heparin tubes. Frozen specimens in glass collection tubes.
Ambient: 72 hours; Refrigerated: 1 week; Frozen: 1 month.
|0097720||Factor V Leiden (F5) R506Q Mutation||Negative: This sample is negative for factor V Leiden, R506Q mutation.|
|0055655||Methylenetetrahydrofolate Reductase (MTHFR) 2 Variants||Negative: Neither of the MTHFR variants tested, c.665C>T (previously designated C677T) and c.1286A>C (previously designated A1298C), were detected. Other causes of elevated homocysteine levels were not evaluated.|
|0056060||Prothrombin (F2) c.*97G>A (G20210A) Pathogenic Variant|
Refer to report
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
Laboratory Developed Test (LDT)
81240; 81241; 81291
|Component Test Code*||Component Chart Name||LOINC|
- FVL R506Q, MTHFR, and Factor II mutation panel
- Hypercoagulable Panel